Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Endogenous 4-1BB ligand plays a critical role in protection from influenza-induced disease.

Lin GH, Sedgmen BJ, Moraes TJ, Snell LM, Topham DJ, Watts TH.

J Immunol. 2009 Jan 15;182(2):934-47.

2.

Intrinsic 4-1BB signals are indispensable for the establishment of an influenza-specific tissue-resident memory CD8 T-cell population in the lung.

Zhou AC, Wagar LE, Wortzman ME, Watts TH.

Mucosal Immunol. 2017 Sep;10(5):1294-1309. doi: 10.1038/mi.2016.124. Epub 2017 Jan 4.

PMID:
28051085
3.

4-1BB ligand activates bystander dendritic cells to enhance immunization in trans.

Macdonald DC, Hotblack A, Akbar S, Britton G, Collins MK, Rosenberg WC.

J Immunol. 2014 Nov 15;193(10):5056-64. doi: 10.4049/jimmunol.1301723. Epub 2014 Oct 10.

4.

A role for IL-15 in the migration of effector CD8 T cells to the lung airways following influenza infection.

Verbist KC, Cole CJ, Field MB, Klonowski KD.

J Immunol. 2011 Jan 1;186(1):174-82. doi: 10.4049/jimmunol.1002613. Epub 2010 Nov 22.

5.

4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.

Cannons JL, Lau P, Ghumman B, DeBenedette MA, Yagita H, Okumura K, Watts TH.

J Immunol. 2001 Aug 1;167(3):1313-24.

7.

IL-15-dependent induction of 4-1BB promotes antigen-independent CD8 memory T cell survival.

Pulle G, Vidric M, Watts TH.

J Immunol. 2006 Mar 1;176(5):2739-48.

8.

Dispensable role for 4-1BB and 4-1BBL in development of vaccinia virus-specific CD8 T cells.

Zhao Y, Croft M.

Immunol Lett. 2012 Jan 30;141(2):220-6. doi: 10.1016/j.imlet.2011.10.008. Epub 2011 Oct 20.

9.

Constitutive interaction between 4-1BB and 4-1BBL on murine LPS-activated bone marrow dendritic cells masks detection of 4-1BBL by TKS-1 but not 19H3 antibody.

Mbanwi AN, Lin GHY, Wang KC, Watts TH.

J Immunol Methods. 2017 Nov;450:81-89. doi: 10.1016/j.jim.2017.08.001. Epub 2017 Aug 5.

PMID:
28789924
10.
11.
12.

A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo.

Bertram EM, Dawicki W, Sedgmen B, Bramson JL, Lynch DH, Watts TH.

J Immunol. 2004 Jan 15;172(2):981-8.

13.

During viral infection of the respiratory tract, CD27, 4-1BB, and OX40 collectively determine formation of CD8+ memory T cells and their capacity for secondary expansion.

Hendriks J, Xiao Y, Rossen JW, van der Sluijs KF, Sugamura K, Ishii N, Borst J.

J Immunol. 2005 Aug 1;175(3):1665-76.

14.

4-1BB and OX40 act independently to facilitate robust CD8 and CD4 recall responses.

Dawicki W, Bertram EM, Sharpe AH, Watts TH.

J Immunol. 2004 Nov 15;173(10):5944-51.

15.

Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge.

Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, McKinstry KK, Cooper AM, Swain SL, Dutton RW.

J Immunol. 2009 Mar 15;182(6):3469-81. doi: 10.4049/jimmunol.0801814.

16.

Potential role of invariant NKT cells in the control of pulmonary inflammation and CD8+ T cell response during acute influenza A virus H3N2 pneumonia.

Paget C, Ivanov S, Fontaine J, Blanc F, Pichavant M, Renneson J, Bialecki E, Pothlichet J, Vendeville C, Barba-Spaeth G, Huerre MR, Faveeuw C, Si-Tahar M, Trottein F.

J Immunol. 2011 May 15;186(10):5590-602. doi: 10.4049/jimmunol.1002348. Epub 2011 Apr 13. Erratum in: J Immunol. 2011 Aug 1;187(3):1515. Barba-Speath, Giovanna [corrected to Barba-Spaeth, Giovanna].

17.

4-1BB ligand signaling to T cells limits T cell activation.

Eun SY, Lee SW, Xu Y, Croft M.

J Immunol. 2015 Jan 1;194(1):134-41. doi: 10.4049/jimmunol.1401383. Epub 2014 Nov 17.

18.

Contribution of 4-1BBL on radioresistant cells in providing survival signals through 4-1BB expressed on CD8⁺ memory T cells in the bone marrow.

Lin GH, Edele F, Mbanwi AN, Wortzman ME, Snell LM, Vidric M, Roth K, Hauser AE, Watts TH.

Eur J Immunol. 2012 Nov;42(11):2861-74. doi: 10.1002/eji.201242503. Epub 2012 Sep 20.

19.

The magnitude of the T cell response to a clinically significant dose of influenza virus is regulated by TRAIL.

Brincks EL, Gurung P, Langlois RA, Hemann EA, Legge KL, Griffith TS.

J Immunol. 2011 Nov 1;187(9):4581-8. doi: 10.4049/jimmunol.1002241. Epub 2011 Sep 21.

20.

Supplemental Content

Support Center